In a recent study, Levy et al. showed that presence of EGFR mutations was associated with low tumor grade suggesting that the difference in prognosis observed among studies just reflects the different biology of the tumor in the two ethnic groups [51]. The gene discussed is EGFR; the disease is neoplasm.